- Home
- CLDX vs PMT Comparison
CLDX vs PMT Comparison
Compare CLDX & PMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- PMT
- Stock Information
- Founded
- CLDX N/A
- PMT 2009
- Country
- CLDX United States
- PMT United States
- Employees
- CLDX N/A
- PMT N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- PMT Real Estate Investment Trusts
- Sector
- CLDX Health Care
- PMT Real Estate
- Exchange
- CLDX Nasdaq
- PMT Nasdaq
- Market Cap
- CLDX 1.3B
- PMT 1.1B
- IPO Year
- CLDX 2008
- PMT 2009
- Fundamental
- Price
- CLDX $20.66
- PMT $11.99
- Analyst Decision
- CLDX Buy
- PMT Hold
- Analyst Count
- CLDX 9
- PMT 6
- Target Price
- CLDX $50.00
- PMT $14.20
- AVG Volume (30 Days)
- CLDX 843.8K
- PMT 938.8K
- Earning Date
- CLDX 08-07-2025
- PMT 07-22-2025
- Dividend Yield
- CLDX N/A
- PMT 13.37%
- EPS Growth
- CLDX N/A
- PMT N/A
- EPS
- CLDX N/A
- PMT 0.72
- Revenue
- CLDX $5,790,000.00
- PMT $614,826,000.00
- Revenue This Year
- CLDX N/A
- PMT N/A
- Revenue Next Year
- CLDX N/A
- PMT $22.22
- P/E Ratio
- CLDX N/A
- PMT $16.64
- Revenue Growth
- CLDX N/A
- PMT 13.07
- 52 Week Low
- CLDX $14.40
- PMT $11.70
- 52 Week High
- CLDX $47.00
- PMT $14.93
- Technical
- Relative Strength Index (RSI)
- CLDX 40.75
- PMT 39.45
- Support Level
- CLDX $20.65
- PMT $11.91
- Resistance Level
- CLDX $22.60
- PMT $12.17
- Average True Range (ATR)
- CLDX 1.11
- PMT 0.26
- MACD
- CLDX -0.28
- PMT -0.04
- Stochastic Oscillator
- CLDX 10.64
- PMT 21.76
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.